- Home
- TROO vs FBRX Comparison
TROO vs FBRX Comparison
Compare TROO & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- FBRX
- Stock Information
- Founded
- TROO 2005
- FBRX N/A
- Country
- TROO Hong Kong
- FBRX United States
- Employees
- TROO N/A
- FBRX N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- TROO Technology
- FBRX Health Care
- Exchange
- TROO Nasdaq
- FBRX Nasdaq
- Market Cap
- TROO 169.8M
- FBRX 154.5M
- IPO Year
- TROO N/A
- FBRX N/A
- Fundamental
- Price
- TROO $1.52
- FBRX $11.93
- Analyst Decision
- TROO
- FBRX Strong Buy
- Analyst Count
- TROO 0
- FBRX 3
- Target Price
- TROO N/A
- FBRX $68.00
- AVG Volume (30 Days)
- TROO 293.0K
- FBRX 95.1K
- Earning Date
- TROO 11-14-2025
- FBRX 11-13-2025
- Dividend Yield
- TROO N/A
- FBRX N/A
- EPS Growth
- TROO N/A
- FBRX N/A
- EPS
- TROO N/A
- FBRX N/A
- Revenue
- TROO $15,084,000.00
- FBRX N/A
- Revenue This Year
- TROO N/A
- FBRX N/A
- Revenue Next Year
- TROO N/A
- FBRX N/A
- P/E Ratio
- TROO N/A
- FBRX N/A
- Revenue Growth
- TROO 247.24
- FBRX N/A
- 52 Week Low
- TROO $0.49
- FBRX $4.11
- 52 Week High
- TROO $3.05
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- TROO 67.86
- FBRX 42.59
- Support Level
- TROO $1.33
- FBRX $11.00
- Resistance Level
- TROO $1.55
- FBRX $12.36
- Average True Range (ATR)
- TROO 0.12
- FBRX 1.06
- MACD
- TROO 0.01
- FBRX -0.39
- Stochastic Oscillator
- TROO 97.22
- FBRX 21.08
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).